AVAdeno Study: An Observational Study of First-Line Avastin (Bevacizumab) in Patients With Adenocarcinoma of the Lung

Clinical trial NCT01827852 · COMPLETED

Trial details

NCT number: NCT01827852
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Non-Squamous Non-Small Cell Lung Cancer

Start date: 2013-03-14
Primary completion: 2017-05-31
Enrollment: 1107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.